Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03515798 | Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer(PELICAN) | active not recruiting | Phase 2 | 52 | Institut Paoli-CalmettesOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT04335669 | NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC | active not recruiting | Phase 3 | 325 | Lund University HospitalOTHER | 2 | Sep 12, 2025 | clinicaltrials |
| NCT06522971 | Effects of Physical Exercise on Response to Treatement in Breast Cancer(CancerBeat) | active not recruiting | N/A | 55 | Latvian Biomedical Research and Study CentreOTHER_GOV | 1 | Sep 10, 2025 | clinicaltrials |
| NCT03585621 | Stereotactic Body Radiation Therapy for Breast Cancer | active not recruiting | N/A | 24 | Toronto Sunnybrook Regional Cancer CentreOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT04759248 | Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer(ATREZZO) | active not recruiting | Phase 2 | 55 | SOLTI Breast Cancer Research GroupOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT04379570 | Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy | active not recruiting | Phase 3 | 1,167 | Alliance for Clinical Trials in OncologyOTHER | 1 | Sep 8, 2025 | clinicaltrials |
| NCT05063786 | Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET)(ALPHABET) | active not recruiting | Phase 3 | 27 | Spanish Breast Cancer Research GroupOTHER | 6 | Sep 8, 2025 | clinicaltrials |
| NCT07154771 | Development and Usability Evaluation of an Arm Circumference Measurement Tool For Patients Undergoing Breast Surgery | active not recruiting | N/A | 35 | Saglik Bilimleri Universitesi Gulhane Tip FakultesiOTHER | 1 | Sep 4, 2025 | clinicaltrials |
| NCT02608216 | [18F]FLT PET/CT in Rb+ Metastatic Breast Cancer | active not recruiting | Phase 1 | 20 | University of PennsylvaniaOTHER | 1 | Sep 3, 2025 | clinicaltrials |
| NCT04134598 | ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast Cancer(EUROPA) | active not recruiting | Phase 3 | 926 | Azienda Ospedaliero-Universitaria CareggiOTHER | 1 | Aug 29, 2025 | clinicaltrials |
| NCT05629065 | Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)((PATH-SIC)) | active not recruiting | N/A | 800 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 28, 2025 | clinicaltrials |
| NCT06253182 | Psychosexual Educational Partners Program (PEPP)(PEPP) | active not recruiting | N/A | 60 | The University of Tennessee, KnoxvilleOTHER | 1 | Aug 24, 2025 | clinicaltrials |
| NCT03165487 | Comparison of the Breast Tumor Microenvironment | active not recruiting | — | 14 | Columbia UniversityOTHER | 1 | Aug 22, 2025 | clinicaltrials |
| NCT05258539 | Breast Cancer Prevention and Screening Membership(AdDePi_KS) | active not recruiting | N/A | 189 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Aug 22, 2025 | clinicaltrials |
| NCT06599216 | Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR + / HER2- Breast Cancer | active not recruiting | Phase 2 | 30 | Harbin Medical UniversityOTHER | 1 | Aug 21, 2025 | clinicaltrials |
| NCT03216421 | Intraoperative Radiation Therapy (IORT) in DCIS | active not recruiting | N/A | 265 | Columbia UniversityOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT06198751 | A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer | active not recruiting | Phase 2 | 104 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Aug 19, 2025 | clinicaltrials |
| NCT03170960 | Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors | active not recruiting | Phase 1 | 914 | ExelixisINDUSTRY | 9 | Aug 17, 2025 | clinicaltrials |
| NCT03958136 | Clinico-biological Data Collection Study of Metastatic Breast Cancer(EPICURE_SEIN) | active not recruiting | N/A | 289 | Institut Cancerologie de l'OuestOTHER | 1 | Aug 17, 2025 | clinicaltrials |
| NCT06036121 | A Study of ADRX-0706 in Select Advanced Solid Tumors | active not recruiting | Phase 1 | 144 | Adcentrx TherapeuticsINDUSTRY | 2 | Aug 17, 2025 | clinicaltrials |
| NCT05486182 | Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer(ESTROTIMP) | active not recruiting | Phase 4 | 153 | GE HealthcareINDUSTRY | 1 | Aug 14, 2025 | clinicaltrials |
| NCT05690828 | Evaluation of Cognitive Management for Chemobrain in Patients Treated for Breast Cancer.(e-ONCOGITE) | active not recruiting | N/A | 164 | Institut BergoniéOTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT05057013 | A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours | active not recruiting | Phase 1 / Phase 2 | 81 | Cancer Research UKOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT03904173 | Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer(EMIT) | active not recruiting | — | 2,300 | Oslo University HospitalOTHER | 1 | Aug 8, 2025 | clinicaltrials |
| NCT04497285 | Real World Study Using Comprehensive Genomic Data on the Next Treatment Decision Making in Metastatic Breast Cancer(HOPE) | active not recruiting | — | 600 | SOLTI Breast Cancer Research GroupOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT06224244 | External Hypofractionated Radiotherapy With Simultaneous Integrated Boost in Early Breast Cancer Patients(ESIBIRE) | active not recruiting | Phase 2 | 180 | Regina Elena Cancer InstituteOTHER | 1 | Jul 25, 2025 | clinicaltrials |
| NCT05802225 | Clinical Study of the Efficacy and Safety of BCD-178 and Perjeta® as Neoadjuvant Therapy of HER2-Positive Breast Cancer(PREFER) | active not recruiting | Phase 3 | 398 | BiocadINDUSTRY | 1 | Jul 20, 2025 | clinicaltrials |
| NCT05257395 | A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer | active not recruiting | Phase 3 | 397 | Xuanzhu Biopharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 17, 2025 | clinicaltrials |
| NCT02436993 | Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab | active not recruiting | Phase 2 | 120 | University of California, IrvineOTHER | 1 | Jul 14, 2025 | clinicaltrials |
| NCT03725059 | Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756) | active not recruiting | Phase 3 | 1,240 | Merck Sharp & Dohme LLCINDUSTRY | 24 | Jul 11, 2025 | clinicaltrials |
| NCT02401685 | POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer(POSNOC) | active not recruiting | N/A | 1,900 | University Hospitals of Derby and Burton NHS Foundation TrustOTHER | 3 | Jul 10, 2025 | clinicaltrials |
| NCT04083963 | Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer | active not recruiting | Phase 2 | 13 | University of Illinois at ChicagoOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT03578484 | Breast Aesthetics by Three Dimensional Measures | active not recruiting | — | 32 | Sykehuset TelemarkOTHER_GOV | 1 | Jul 4, 2025 | clinicaltrials |
| NCT07048639 | Dosimetric Evaluation of Breathing Impact on PTV and Adjacent Organ At Risk in Breast Cancer Radiotherapy | active not recruiting | — | 22 | Superior UniversityOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT07044791 | Metabolic Parameters and Quality of Life in Women on Neo-/Adjuvant Therapy for Breast Cancer | active not recruiting | N/A | 120 | Federico II UniversityOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT07046195 | Optimal Combination of Adjuvant Radiotherapy and Immunotherapy for Breast Cancer | active not recruiting | — | 250 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT03831178 | Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting(DHA-WIN) | active not recruiting | Phase 2 | 76 | AHS Cancer Control AlbertaOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT05520515 | Water and Land-based Aerobic Training in Breast Cancer Survivors(WaterMama) | active not recruiting | N/A | 48 | Federal University of PelotasOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT06394661 | Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer | active not recruiting | Phase 2 | 109 | Henan Cancer HospitalOTHER_GOV | 1 | Jun 23, 2025 | clinicaltrials |
| NCT04541212 | Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia(CarChem) | active not recruiting | — | 169 | Montreal Heart InstituteOTHER | 1 | Jun 15, 2025 | clinicaltrials |
| NCT05104632 | Financial Toxicity in Breast Cancer Surgery | active not recruiting | — | 630 | McMaster UniversityOTHER | 1 | Jun 15, 2025 | clinicaltrials |
| NCT07018427 | Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer | active not recruiting | — | 70 | Peking University Cancer Hospital & InstituteOTHER | 1 | Jun 12, 2025 | clinicaltrials |
| NCT02788981 | Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer | active not recruiting | Phase 2 | 29 | University of ChicagoOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT02804815 | Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours | active not recruiting | Phase 3 | 11,000 | University College, LondonOTHER | 2 | Jun 10, 2025 | clinicaltrials |
| NCT05346224 | A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer | active not recruiting | Phase 3 | 900 | Shanghai Henlius BiotechINDUSTRY | 4 | Jun 10, 2025 | clinicaltrials |
| NCT01953159 | Assessment of Paclitaxel-Induced Neuropathy | active not recruiting | — | 43 | University of ChicagoOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT03147430 | Early Detection of Breast Cancer in Women With Suspicious Mammograms | active not recruiting | — | 270 | Sentara Norfolk General HospitalOTHER | 1 | Jun 6, 2025 | clinicaltrials |
| NCT07008508 | Incidence of Venous Thromboembolism and Cardiovascular Events in Breast Cancer Patients Undergoing Cyclin-dependent Kinase 4/6 Inhibitors: The Breast Cancer Associated Vascular Events During Cyclin-dependent Kinase 4/6 Inhibitors Therapy (BRAVE-Cyclin) Study(BRAVE-Cyclin) | active not recruiting | — | 300 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jun 6, 2025 | clinicaltrials |
| NCT02546232 | Improved Breast Cancer Therapy (I-BCT-1) in the Neoadjuvant and Metastatic Setting | active not recruiting | Phase 2 | 196 | Oslo University HospitalOTHER | 1 | Jun 4, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Sep 12, 2025source: clinicaltrials